1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Venous Stents Market to 2025 - Global Analysis and Forecasts

Venous Stents Market to 2025 - Global Analysis and Forecasts

  • November 2018
  • 115 pages
  • ID: 5653787
  • Format: PDF
  • By The Insight Partners

Summary

Table of Contents

Search Inside

In the report the venous stents market, the market is expected to reach US$ $ 1,727.4 Mn in 2025 from US$ 829.0 in 2017. The market is estimated to grow with a CAGR of 9.7% from 2018-2025.
The venous stents market is driven by the driving factor such as rising prevalence of venous diseases, technology advancement in stents technology and rising global geriatric population.The trend of development of advanced venous stents are likely to propel the growth of the market.

However, the factors such as stringent regulations for approval and high cost of surgical procedures are likely to restraint the market in the forecast period.
The venous stents market as per the technology the segment is segmented as wallstent technology, iliac vein stent technology. The market of iliac vein stent technology segment has the highest market share in 2017, contributing to venous stents market is of 73.9% and is expected to retain its dominance during the forecast period from 2018 to 2025. The development for the venous stents are done such that they are dedicated for the treatment of iliac venous obstruction are flexible, possess good radial force, MRI compatible, and are inexpensive. These technological advancements are enhancing accuracy, enabling additional capabilities to improve the workflow, and aiding in error reduction. Similarly, the wallstent technology segment contributed 26.1% of the market share in the year 2017 and is expected to be the fastest growing market in the coming forecast period.
The application segment of the venous stents market includes legs, chest, abdomen and arm. The application segment for the venous stents market was valued at US$ 36.82 Mn in 2017 and is estimated to reach US$ 63.39 Mn by 2025. The legs segments is likely to dominate the market in the coming future owing to the increasing incidences of the Deep Vein Thrombosis (DVT), growing geriatric population and increasing technological advancements to treat DVT are likely to enhance venous stents market. The chest segments are the fastest growing segment in the application and is expected to be the fastest growing segment in the forecast period owing to rising preference for minimally invasive procedures, rising incidences of chronic lung diseases, increasing prevalence of congenital diseases and growing obesity within the population are likely to propel the growth of the venous stents market.
Some of the major primary and secondary sources included in the report venous stents market are, World Health Organization, Center of Centers for Disease Control and Prevention (CDC), Venous Association of India (VAI), European Commission, Clinical Journal of American Society of Nephrology, NHS England, Allied Academies, Ministry of Health, Labour and Welfare and more.

Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the orthopedic braces and supports market.
-Highlights key business priorities in order to assist companies to realign their business strategies.
-The key findings and recommendations highlight crucial progressive industry trends in the global orthopedic braces and supports market, thereby allowing players across the value chain to develop effective long-term strategies.
-Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
-Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
-Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Deep Vein Thrombosis (DVT) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

Global Deep Vein Thrombosis (DVT) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

  • $ 1799
  • August 2019

High levels of pipeline activity are being observed in Deep Vein Thrombosis (DVT) treatment during 2019. Clinical development activities are being undertaken by more than 5 companies including CarboMimetics, ...

Global Pulmonary Embolism Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

Global Pulmonary Embolism Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

  • $ 1799
  • August 2019

High levels of pipeline activity are being observed in Pulmonary Embolism treatment during 2019. Clinical development activities are being undertaken by more than 5 companies including Daiichi Sankyo Co ...

Coronary Stents Market - Global Outlook and forecast 2019-2024

Coronary Stents Market - Global Outlook and forecast 2019-2024

  • $ 3500
  • July 2019

The global coronary stent market is likely to reach more than $11 billion by 2024, growing at a CAGR of around 7% during 2018–2024.The emergence of bioresorbable vascular scaffolds, the high growth potential ...


ref:plp2018

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on